In our study, differential expression analysis confirmed significant upregulation of ITGB6 and LTBP1 in DKD patients and in high-glucose–treated MPC5 podocytes, consistent with their established roles in ECM remodeling and fibrotic signaling (Ducceschi et al., 2014). Here, ITGB6 is linked to diabetic kidney disease.